Integrated genetic and epigenetic analysis identifies that rs939408 affects non-smoking lung adenocarcinoma risk by modulating the DNA methylation of LRRC2
本研究通过整合遗传和表观遗传分析，识别出rs939408作为影响非吸烟者肺腺癌风险的关键因素。研究发现，rs939408通过调节LRRC2的DNA甲基化水平，进而影响其表达，降低肺腺癌的发生风险。LRRC2的高表达被证明可以抑制LUAD细胞的恶性表型，并与患者的预后相关。这些发现为LUAD的早期诊断和治疗提供了新的生物标志物和潜在靶点。
HMOX1 interacts with BNIP3 to modulate neuronal ferroptosis after spinal cord ischemia-reperfusion injury via a mitophagy-dependent mechanism
本研究揭示了HMOX1在脊髓缺血再灌注损伤中的关键作用，强调其在铁死亡和线粒体自噬中的调节功能。HMOX1的敲低促进了SCIRI大鼠的神经功能恢复，表明其作为潜在治疗靶点的前景。研究结果为脊髓损伤的治疗提供了新的见解，强调了HMOX1与BNIP3的相互作用在调节细胞死亡中的重要性。
BRD4 inhibition suppresses histone H4 UFMylation to increase ferroptosis sensitivity through TXNIP
BRD4抑制剂JQ1通过抑制组蛋白H4的UFMylation，增加TXNIP的表达，从而增强肝癌细胞对铁死亡的敏感性。研究表明，TXNIP在细胞周期调控中发挥重要作用，JQ1的应用可能为癌症治疗提供新的策略。该研究为BRD4作为癌症治疗靶点的潜力提供了新的见解，强调了TXNIP在调节细胞对治疗反应中的关键角色。
CNOT7 facilitates radiation resistance in colorectal cancer through TRIM21/XRCC6-mediated non-homologous end joining repair
研究发现CNOT7在结直肠癌放疗抵抗中起关键作用，通过调节XRCC6的泛素化来影响DNA损伤修复。高表达CNOT7与患者不良预后相关，CNOT7缺失可增强放疗敏感性，提示其作为潜在治疗靶点的价值。此外，结合XRCC6抑制剂STL127705可显著提高放疗效果，为临床应用提供了新思路。
Circular RNA CLASP1 modulates the GLI1/SNAIL axis and enhances macrophage polarization in breast cancer
研究发现circCLASP1在乳腺癌中显著上调，并与肿瘤进展相关。通过调节GLI1/SNAIL轴，circCLASP1增强巨噬细胞极化，促进乳腺癌细胞的增殖和转移。这一发现为乳腺癌的预后生物标志物和治疗靶点提供了新的视角，具有重要的临床应用潜力。
Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models
The study reveals that the combination of sorafenib, an FDA-approved multi-targeted kinase inhibitor, and LZX-2-73, a novel NUPR1 inhibitor, exhibits strong synergistic anticancer effects across multiple cancer models, particularly in pancreatic cancer. This combination enhances therapeutic efficacy by inducing oxidative stress and promoting cell death, offering a promising strategy to overcome drug resistance in cancer treatment. The findings suggest that targeting NUPR1 could broaden the clinical application of sorafenib and improve outcomes for cancer patients.
CMKLR1/PKA signaling reinforces sonic hedgehog pathway to promote medulloblastoma pathogenesis
CMKLR1信号通路通过激活PI3K/Akt通路促进SHH亚型髓母细胞瘤的生长和迁移。研究发现，CMKLR1的表达与肿瘤进展密切相关，且其在SHH信号通路中的作用为髓母细胞瘤的致病机制提供了新的见解。这一发现为未来的靶向治疗和投资机会提供了潜在的基础。
Knockdown of SUCLG2 inhibits glioblastoma proliferation and promotes apoptosis through LMNA acetylation and the mediation of H4K16la lactylation
SUCLG2在胶质母细胞瘤（GBM）中的作用研究显示，其敲除可显著抑制细胞增殖并促进凋亡。研究揭示SUCLG2通过调控LMNA的乙酰化和H4K16la的乳酸化影响线粒体代谢，进而影响肿瘤细胞的生长。这一发现为GBM的治疗提供了新的靶点，具有重要的临床和商业潜力。
A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia
M2T-CD33是一种新型的MHC II靶向免疫疗法，针对急性髓性白血病（AML）中的CD33抗原。研究显示，该疗法在小鼠模型中有效诱导了针对CD33的免疫应答，并且在与抗PD-1疗法联合使用时显著提高了生存率。M2T-CD33在高剂量下未显示出明显的毒性，表明其具有良好的安全性特征，预示着其在临床应用中的潜力。
Chrysanthemum morifolium extract improves metabolic dysfunction-associated fatty liver disease by regulating lipid metabolism
Chrysanthemum morifolium extract has been shown to effectively improve metabolic dysfunction-associated fatty liver disease (MAFLD) by regulating lipid metabolism. The study highlights its ability to inhibit lipid synthesis via the SREBP-1c/FAS/ACCα pathway and enhance fatty acid oxidation through the PPARα/CPT-1 pathway. These findings suggest a promising direction for developing therapeutic agents for MAFLD, addressing a significant global health concern.
Distinct functional heterogeneity of TP53 R175 mutations in platinum-resistant ovarian cancer: unveiling molecular mechanisms and therapeutic targets
该研究探讨了TP53 R175突变在铂耐药卵巢癌中的功能异质性，发现R175H和R175G突变在肿瘤细胞迁移和药物耐受性方面具有显著差异。通过多组学分析，研究揭示了这两种突变的不同分子机制，特别是R175G突变通过IL7R信号通路促进肿瘤进展。研究结果为铂耐药卵巢癌的个性化治疗提供了新的靶点和策略，强调了针对特定突变的治疗方法的重要性。
Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation
本研究探讨了BCL9在肝细胞癌（HCC）免疫逃逸中的作用，发现其表达与患者对免疫检查点抑制剂（ICI）治疗的反应相关。研究开发了hsBCL9Z96肽，能够通过调节巨噬细胞表型，增强抗肿瘤免疫反应，从而逆转免疫耐受。该研究为HCC的治疗提供了新的策略，具有重要的临床和商业潜力。
YTHDF3 promotes breast cancer osteolytic bone metastasis by enhancing the translation of ZEB1 and SMAD5
研究表明，YTHDF3在乳腺癌骨转移中发挥重要作用，通过增强ZEB1和SMAD5的翻译促进癌细胞的迁移和侵袭。YTHDF3的高表达与乳腺癌患者的预后相关，可能成为新的治疗靶点。该研究为乳腺癌的治疗提供了新的思路，具有较高的商业潜力。
Drug-tolerant persister cells in cancer: bridging the gaps between bench and bedside
Drug-tolerant persister cells (DTPs) are a significant challenge in achieving lasting cancer remission due to their ability to survive standard therapies. This article discusses the biological characteristics of DTPs, including their adaptive mechanisms and the need for innovative research approaches that integrate clinical complexities. It highlights the importance of understanding DTPs to develop effective therapies and actionable biomarkers, ultimately aiming to bridge the gap between laboratory research and clinical application.
RAF inhibitors activate the integrated stress response by direct activation of GCN2
本研究揭示了RAF抑制剂通过直接激活GCN2来激活整合应激反应（ISR），影响细胞增殖。这一发现对癌症治疗具有重要意义，尤其是在BRAF突变相关的癌症中，可能会影响临床治疗效果和投资策略。